Prodrug behaviour of nicotinoylmorphine esters

Area of Science:

• Pharmacology
• Neuroscience
• Medicinal Chemistry

Background:

• Morphine is a potent opioid analgesic with a well-established efficacy.
• Nicotinoyl esters of morphine represent potential prodrugs with modified pharmacokinetic and pharmacodynamic profiles.
• Understanding the time-effect relationships of these derivatives is crucial for optimizing their therapeutic potential.

Purpose of the Study:

• To compare the central activity of morphine and its nicotinoyl esters: dinicotinoylmorphine (nicomorphine), 6-mononicotinoylmorphine (6-MNM), and 3-mononicotinoylmorphine (3-MNM).
• To establish the time-effect profiles for analgesia and locomotor stimulation in rodent models.
• To investigate the prodrug characteristics of these morphine derivatives.

Main Methods:

• Assessment of central activity in mice using the hot plate test for analgesia.
• Measurement of locomotor stimulation in activity cages.
• Pharmacokinetic and pharmacodynamic analysis to determine time-effect profiles.

Main Results:

• Nicomorphine, 6-MNM, and 3-MNM exhibited a faster onset of action compared to morphine.
• The duration of analgesic and stimulatory effects differed among the tested compounds.
• 3-MNM and morphine demonstrated longer-lasting effects than nicomorphine and 6-MNM.

Conclusions:

• Morphine nicotinoyl esters display distinct time-effect profiles compared to the parent drug, morphine.
• The observed differences suggest varying degrees of prodrug conversion and/or direct activity.
• These findings provide insights into the pharmacokinetic behavior and potential therapeutic applications of morphine derivatives.